The characteristic features of sarcomas induced in mice by Moloney murine sarcoma virus (MSV-M), 1 namely rapid development and spontaneous regression, have prompted extensive investigations on humoral and cell immune response in this model (1). A cause-and-effect correlation between immune response and tumor regression can be concluded from observations in immunologically incompetent hosts. In X-ray-irradiated (2), thymus-deprived (3, 4), or congenitally athymic mice (5, 6), Moloney sarcomas always show progressive growth. In immunocompetent mice, the majority of Moloney sarcomas completely regress, though few may continue to grow or recur later (7-12). It has been proposed that this recurrence is due to the disappearance of a resistance state acquired during tumor regression (10), although the possibility that the recurrent tumor may differ from the primary one with respect to, for instance, immunosensitivity and]or antigenicity, was not considered. We have therefore studied the virological, oncogenic, and antigenic properties of a transplantable tumor that reappeared at the site of a primary regressed Moloney sarcoma. Also, two oncogenic cell lines derived from this tumor, and for comparative purposes, ascitic MSV-M-producing cells (13) and a Moloney helper virusproducing cell line established from these ascitic cells were included in these studies. The purpose of this investigation was to obtain information on the escape mechanism of tumor cells from immune destruction.
maintained for more than 4 yr by intraperitoneal (i.p.) inoculations at weekly intervals. The Bc cell line was established from the asc-MSV-M.
Recurrent Secondary Tumor (ST) and Its Culture Derivatives.
A 5-wk-old STU mouse was injected i.m. with 104 focus-forming units (flu) in 0.1 ml of a MSV-M-turnor homogenate, and developed a palpable tumor 7 days later. After peak tumor development, regression followed and was complete 3 wk later, as far as could be assessed by palpation. 6 wk ai~r the regression of the primary MSV-M-induced tumor, a second tumor developed at the same site. Single cell suspensions for transplantation were obtained by mincing parts of the peripheral tumor mass followed by filtration through sterile gauze. After washing once in phosphate-buffered saline (PBS) supplemented with antibiotics, a milky suspension of cells was transferred i.m. into four 4-to 5-wk-old unconditioned STU mice. 2 wk after transplantation, tumor development was observed in the recipients. The tumor has since been maintained for more than 2 yr by serial parallel i.m. and i.p. inoculations at intervals of 2-4 wk in the case ofi.m, transplantation, and at weekly intervals with the ascitic form. A nonproducer cell line was established from the ascitic form [Sac (-) Virus Assays. Focus and XC plaque assays, [3H]uridine incorporation, and electron microscopic studies were performed by applying usual procedures (17) (18) (19) (20) .
Light Microscopy. Cell monolayers in plastic Petri dishes were fixed with Bouin's solution and stained with hemalum and eesin.
Determination of Tumorigenicity. Tumor induction was determined by i.m. inoculation of carefully graded doses of the various cells in a 0.1-ml volume into STU mice of at least 6 wk of age. In addition, ~ 10 s Bc cells were inoculated into newborn mice. The tumorigenic potency of supernates from Sac(+) cultures was investigated in adult mice using clarified cell-free culture fluid undiluted. Development of tumors was observed for at least 42 days. In the case of Bc cells transplanted into adult mice, the observation period was extended over a period of 12 mo.
Transplantation Protection Assay. The ability of the various cells to induce transplantation resistance to asc-MSV-M, ST, Sac(-), and Sac(+) cells was compared by i.m. inoculation of viable asc-MSV-M (105 nuclear cells), ST (10 s cells), Sac(-) (5 × 103 cells), Sac(+) (5 × 103 cells), or Bc
(103 cells) cells into the right thigh of STU mice ~ 6 wk of age. Challenge was performed by i.m. inoculation of graded doses of tumor cells into the left thigh ~ 2 wk later; at this time asc-MSV-M cell-induced tumors began to regress, tumors induced by the above-mentioned relatively small number of Sac(+) cells also started to regress or showed deadlock of tumor growth, and at the sites where ST and Sac(-) cells had been inoculated, tumor growth became visible. In addition, mice that had received 106 Bc cells were challenged 1 yr later with asc-MSV-M. Age-matched mice that had received no primary inoculation were used as controls. Observation of tumor development after challenge was monitored thrice weekly for at least 40 days; after inoculation of ST or Sac(-) cells the observation period was shorter because of intercurrent death of the tumor bearers. Amputation of limbs bearing ST tumors before challenge in order to increase the survival time was not successful, as fatal metastatic tumors had already developed.
Isolation of gffector Cells and Cytotoxic Antibodies. Inoculation of the above-mentioned cells
was done by injecting the desired number of cells in a 0.1-ml volume i.m. into the thigh region of mice about 6 wk of age. Lymphoid spleen cell suspensions were prepared 8 and 12 days after cell inoculation by the method previously described (14, 15) . Pooled spleen cells of two or three mice were used in each test. Blood from the inoculated mice was taken at the days indicated in Results by puncture of the retro-orbital plexus, and the sera pooled from at least 3 animals were stored at -20°C until use.
[3H]Proline Microcytotoxicity Assay for the Demonstration of Cell-Mediated Cytotoxicity (CMC) and Antibody-Mediated Cytotoxicity (AMC).
A modification of the [3H]proline microcytotoxicity assay ([3H]proline-MA) developed by Bean et al. (21) was used and has been described previously (15) . The assay measures target cell detachment as an expression of cytotoxicity. In the meantime, few minor modifications have been applied. We now prefer the model 48 TC Linbro tissue culture plates (Linbro Chemical Co., Inc., New Haven, Conn.). For assay of CMC, 6 x 103 [3H]prolinelabeled cells in 0.1 ml were added to each well, and for the assay of AMC, the number of cells per 0.1 ml was 3.5 x 10 ~. Subsequently, the cultures were incubated at 37°C in a 5% CO~ incubator.
In the CMC assay, the cells were incubated for 4 h, then lymphoid cells in a 0.05-ml volume were added at ratios indicated in Results. After a 42-h incubation, the plates were dipped twice into PBS supplemented with 2% fetal calf serum at a temperature of 37°C. After trypsinization, the cells were transferred directly into scintillation vials. Calculation of percent reduction of target cells was performed as described previously (15) . For determination of AMC, the target cell cultures were incubated for 16-18 h. Then, the culture supernates were sucked off using a peristaltic pump (Varioperpex, LKB, Stockholm, Sweden) and 0.05 ml of serial threefold dilutions of the sera to be tested were added; after incubation for 1 h at 37°C, 0.05 ml of rabbit complement (C') was added. Before use, a rabbit serum was diluted 1:3 with PBS and then absorbed with agarose (40 mg/ml) for 1 h at 4°C; after centrifugation at 5,000 rpm for 20 rain, and filtration through a membrane with a pore size of 45/~m, the serum was used at a final dilution of 1:9 or 1:12. After addition of rabbit C', the cultures were incubated for 2-3 h at 37°C and subsequently harvested for scintillation counting as described above. Target cells treated with either rabbit C' or the serum dilutions to be tested served as controls. Since sera in the absence of rabbit C' were without cytotoxicity, evaluation was performed by comparing the arithmetic mean of radioactivity of a group comprising three or four replicates treated with a serum dilution and rabbit C' with that of a corresponding control group to which only rabbit C' had been added. The degree of cytotoxic antibody activity is expressed for each serum dilution by the percent reduction of target cell radioactivity taking the radioactivity of the control group as basis for the calculation of the percent reduction. cultures. By contrast, Bc cultures predominantly consisted of flattened, poorly refractile cells (Fig. 1) .
Results

Virological Properties of the
Growth of Tumors Induced in Mice by the Different Cell Lines. * Primary inoculation of cells was done i.m. into the right thigh of 6-wk-uld mice; ~-2 wk later, i.m. challenge inoculation into the left thigh was performed. $ See legend of Fig. 2 . § Ino., groups of mice with primary cell inoculation; C, control groups. II Number of mice with tumors/number of inoculated mice; number in parentheses indicates the day after challenge at which a tumor was palpable. ¶ Intercurront death due to the primary tumor. ** 5 x 10 s and 5 x 104 cells were used for challenge.
concentrations of 102 nuclear cells/0.2 ml, thus indicating the presence of flureleasing cells, since formation of foci induced by the division of transformed nonproducing cells would require more time. Moreover, the foci reacted positively in the XC plaque assay performed 6 days after the beginning of the test. Simultaneously, the tumor cell suspension was transplanted i.m. into normal mice and into mice that had received Sac(+) culture supernate i.m. 11 days before. Doses containing 106 nuclear cells and a 3-, 9-, and 27-fold dilution of it were used. Each group of mice consisted of 5-6 animals. 18 of the 20 mice of the four control groups developed tumors with a progressive (12 cases) or regressive (6 cases) course, whereas no tumor was palpable in the 22 mice pretreated with Sac(+) virus.
After we had obtained the results described above, the virological and growth properties of the different cell strains were designated in the tables and figures as indicated in the legend of Fig. 2 .
Growth of Tumors Caused by Virus Released from Sac(+) Cells.
The observation that the sarcoma-helper virus complex-producing Sac(+) cells induced in many cases progressively growing tumors without regression and also produce focus-and XC plaque-forming virus, prompted us to study whether this virus causes tumor development with growth characteristics similar to that induced by the cells releasing this virus. Intramuscular inoculation of supernates from Sac(+) cells containing 104 flu]0.1 ml was followed by leg enlargement in 25 of 36 mice which was palpable between 6 and 12 days after virus inoculation. The tumors regressed completely in all cases ~3 wk after virus inoculation. None of the regressed tumors reappeared during an observation period of ---2 mo after regression was complete.
Induction of Cross Transplantation Resistance. To study the capacity of the different cell lines to induce homologous and heterologous transplantation immunity, cross tests were performed. Table I 
Comparison of Cultured Cell Lines as Target Cells in CMC and AMC Assays.
Experiments were performed to determine whether or not differences exist between the three cultured cell lines with regard to their sensitivity as The antigenicity of transformed nonproducer murine cells is not regularly demonstrable, and has to be considered to be weak since repeated immunizations are necessary to induce a demonstrable immune response (23) . No immunogenicity of MSV-transformed nonproducer cells was detected by Strouk et al. (24) , and Stephenson and Aaronson (25) , and the failure in the present study of ST and Sac(-) cells to induce an immune response supports these observations. The progressive growth of tumors induced by the nonproducer Sac(-) cells can be explained by their poor antigenicity. A suppression of an immune response in ST tumor-bearers against MSV-M producer tumors could not be deflected in a preceding study (26) .
TABLE HI
Comparison of Three Cell Lines Derived from MSV-M-Induced Tumors as Target Cells in an AMC Assay
The The observation that the sarcoma-helper virus complex-releasing Sac(+) cells and the helper virus-producing Bc cells, both producing the same helper virus, differ in their reactivity against cytotoxic effector cells induced by sarcomahelper virus complex-producing cells is of considerable interest. The relative insensitivity of Sac(+) cells is not mediated by components released from these cells since addition of Sac(+) cells to Bc cells did not decrease the sensitivity of the latter (result not shown). The difference in sensitivity between Bc cells and Sac(+) cells in CMC may be due to a smaller amount of helper virus produced per Sac(+) cell in comparison to Bc cells. However, this difference in the amount of helper virus production is without influence on the sensitivity of the two cells in the AMC assay. Furthermore, in view of the difference in the morphological phenotype between Sac(+) and Bc cells, it would be interesting to study whether or not the insensitivity of Sac(+) cells for CMC in contrast to AMC is due to the reduction of cytoskeletal elements that seems to be correlated with the phenotype in oncornavirus-transformed cells (27, 28) . Such a decrease in number and distribution of cytoplasmic microfilaments may result in an interference with steps in the lytic process in CMC (29, 30) . Besides this, one may consider that H-2 restriction exists in CMC in the MSV-M mouse system (31), and one can speculate that differences in the expression of H-2 between the two cell lines are responsible for their different reactivity against effector cells.
The presented results stress the importance of the cell type used as target cell for the detection of CMC. Contradictory results reported on the demonstration of cytotoxic effector cells in mice with Moloney sarcoma (for review see Levy and Leclerc, 1) can be explained by the use of target cells differing in sensitivity.
The described relative insensitivity of Sac(+) cells (S+L +) against cytotoxic effector cells, and possibly a growth behaviour which protects tumor cells within the tumor mass from immune attack may be responsible for the escape of Sac(+) tumors from immune surveillance. The transplantation resistance of mice preimmunized with producer cells against a challenge with Sac(+) cells may be explained with the assumption that mice that have already mounted a strong CMC and AMC response are able to reject a relatively small number of Sac(+) cells. The observation that the sarcoma-helper virus complex released from Sac(+) cells induced tumors which regress, makes it difficult to assume that the escape of Sac(+) cell-induced tumors from immune destruction is the result of at least some fraction of newly infected cells becoming nonproducer, particularly in the presence of antibodies which neutralized helper virus. This observation makes it more reasonable to assume that the progressive growth of tumors induced by the producer cell line derived from ST cells is a property of these transformed cells per se. Such a property, together with a poor antigenic-ity, may also allow the nonproducer Sac(-) cells to escape from immune surveillance.
Summary
Cells from a secondary tumor developing at the site of a regressed Moloney sarcoma virus-induced tumor could be passaged in adult STU mice by intramuscular and intraperitoneal inoculation. The tumors induced by these cells, as well as by a cell line derived from it, grew progressively and led to death of the animals between 3 and 7 wk after tumor transplantation. No evidence for production of virus from these cells was obtained or for the presence of viral antigens (p30, gp69/71). From both cell variants, sarcoma virus genome could be rescued by infection with helper virus, resulting in the establishment of a cell line producing focus-and XC plaque-forming virus. The rescued producer cells very frequently also produced tumors which finally grew progressively. The nonproducer cells were not immunogenic, as was demonstrated in cross transplantation tests and in studies for cell-mediated cytotoxicity (CMC) and complement-dependent antibody-mediated cytotoxicity (AMC). The producer cells, however, were demonstrated to possess a strong immunogenicity. The nonproducer cells, though nonimmunogenic, revealed a weak immunosensitivity when used for challenge in the transplantation protection assay or as target cell for the demonstration of AMC and CMC, if the immune response was induced by cells producing the sarcoma-helper virus complex, but not by cells producing only helper virus. The nonproducer cells, as well as their rescued producer derivative, showed a stronger reactivity with cytotoxic antibodies than with cytotoxic cells, whereas the helper virus-producing cell line was comparably suitable as target cell for AMC and CMC. The recurrence of a regressed Moloney sarcoma is assumed to be the result of the occurrence of transformed nonproducer cells escaping immune destruction, and not as a consequence of a depleted immune resistance in the host.
